Meridian Holdings

Meridian Bioscience is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic test kits and purified reagents. The company operates through two primary segments: Diagnostics and Life Science. The Diagnostics segment focuses on infectious diseases and gastrointestinal conditions, utilizing technologies such as molecular amplification and rapid immunoassay. The Life Science segment provides essential raw materials, including antigens, antibodies, and specialized PCR master mixes, to other diagnostic manufacturers and researchers globally. In early 2023, the company was acquired by a consortium led by SD Biosensor and SJL Partners, transitioning from a public entity to a private subsidiary.